Share on :

Asset Summary

No data available for Daily Sep 17, 2024, .

Asset Performance Metrics and Risk Characteristics:

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. By using various technical indicators and chart patterns, investors can gain insights into market trends, price momentum, and potential turning points. This section delves into essential technical metrics, including moving averages, pivot points, and other indicators that provide a snapshot of an asset's current technical stance. Analyzing these indicators helps investors identify entry and exit points, assess market sentiment, and refine their trading strategies. Explore the following technical analysis data to understand the asset's performance dynamics and make better-informed decisions.

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Enhance Your XBI Trading Now

Achieve superior trading results with RankMyTrade Platform. Our platform provides expert analysis and actionable insights for XBI, utilizing the latest technology to refine your investment approach. Boost your investment success with us now and see the impact on your trading success!

Start Optimizing Now

Frequently Asked Questions

Similar ETFs to XBI include: IBB (iShares Nasdaq Biotechnology ETF), which tracks the Nasdaq Biotechnology Index and provides exposure to biotech and pharmaceutical companies; LABU (Direxion Daily S&P Biotech Bull 3X Shares), a leveraged ETF seeking to provide three times the daily performance of the S&P Biotechnology Select Industry Index; and IBD (iShares U.S. Biotechnology ETF), which provides exposure to U.S. biotechnology companies, tracking the NYSE Arca Biotechnology Index.

XBI aims to closely track the performance of the S&P Biotechnology Select Industry Index. The ETF’s performance should generally mirror that of the index, though minor discrepancies may occur due to tracking error and management fees.

Yes, XBI can be held in retirement accounts such as IRAs or 401(k)s. It is important to consider how it fits within your overall investment strategy and risk tolerance given its focus on the biotech sector.

Historical performance data for XBI includes past returns, NAV, and volatility. Investors can review performance charts and reports to assess how XBI has tracked its index and how its value has changed over time.

Risks include high volatility and sector-specific risks associated with biotechnology companies. The biotech sector can be highly sensitive to regulatory changes, clinical trial results, and market sentiment, which can lead to significant fluctuations in XBI’s value.

XBI is managed by State Street Global Advisors and tracks the S&P Biotechnology Select Industry Index. The ETF is passively managed, meaning it seeks to replicate the performance of the index by holding the same securities in similar proportions.

Factors influencing XBI’s performance include biotech industry trends, regulatory changes, clinical trial outcomes, market sentiment, and broader economic conditions. The ETF’s performance is also affected by the performance of the underlying index.

XBI has an expense ratio of approximately 0.35%. This fee represents the cost of managing the fund, including administrative and operational expenses, and is expressed as a percentage of the fund’s average net assets.

Investors can purchase shares of XBI through a brokerage account. It is traded on major stock exchanges under the ticker symbol "XBI" and can be bought and sold like other stocks and ETFs.

Key performance metrics for XBI include its net asset value (NAV), expense ratio, average daily trading volume, and total return over various periods (e.g., 1-year, 5-year). NAV reflects the per-share value of the ETF, while total return measures the performance of the fund.

Unleash Your XBI Trading Now

Take control of your trading with RankMyTrade. Our platform offers unparalleled analysis and technical support for XBI, designed to enhance your market performance. Enhance your market performance today today and experience the difference with our expert tools!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. RankMyTrade (RMT) has not independently verified this data and does not guarantee its accuracy. The information and calculations provided by RankMyTrade are for educational and informational purposes only and should not be construed as financial or investment advice.

With any investment, your capital is at risk. The value of your portfolio go down as well as up. Past performance is no guarantee of future results. By using this website, you accept our Terms of Service, Privacy Policy, and Payment Agreement.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind. Unless otherwise noted, RankMyTrade and its affiliates are not partners, affiliates, or licensees of these companies.

Supported Assets & ETFs